Le Lézard
Classified in: Health
Subjects: CCA, SCZ, FVT

Brookdale to Present at the Jefferies 2019 Healthcare Conference


NASHVILLE, Tenn., May 28, 2019 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE: BKD) ("Brookdale" or the "Company") announced today that Lucinda "Cindy" Baier, President and Chief Executive Officer will participate in a discussion regarding the Company at the Jefferies 2019 Healthcare Conference in New York City, New York on Wednesday, June 5, 2019. 

(PRNewsfoto/Brookdale Senior Living Inc.)

The Brookdale discussion will begin at 4:30 pm ET and the live audio webcast can be accessed on the Internet through the Company's website at www.brookdale.com/investor as well as directly at http://wsw.com/webcast/jeff118/bkd/. A replay of the webcast will be available on the Company's website until July 5, 2019. 

About Brookdale Senior Living
Brookdale Senior Living Inc. is the leading operator of senior living communities throughout the United States. The Company is committed to providing senior living solutions primarily within properties that are designed, purpose-built, and operated to provide the highest-quality service, care, and living accommodations for residents. Brookdale operates and manages independent living, assisted living, memory care, and continuing care retirement communities, with 844 communities in 45 states and the ability to serve approximately 80,000 residents as of March 31, 2019. The Company also offers a range of home health, hospice, and outpatient therapy services. Brookdale's stock is traded on the New York Stock Exchange under the ticker symbol BKD.

SOURCE Brookdale Senior Living Inc.


These press releases may also interest you

24 avr 2024
Summit Clinical Research LLC ("Summit") is deeply saddened by the death of Co-Founder and Chairman Dr. Stephen Harrison. Summit mourns Dr. Harrison and extends its heartfelt condolences to his family and loved ones.   During an illustrious 30-year...

24 avr 2024
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

24 avr 2024
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

24 avr 2024
Labcorp , a global leader of innovative and comprehensive laboratory services, announced today that it has been selected as the winning bidder for select assets of Invitae, a leading medical genetics company.  Before the transaction can proceed,...

24 avr 2024
Invitae , a leading medical genetics company, announced that Labcorp , a global leader of innovative and comprehensive laboratory services, has been selected...

24 avr 2024
Valcare Medical, Inc., a leading innovator in transcatheter-based mitral...



News published on and distributed by: